Table 2.
Association between fibrinogen and 90-day mortality.
| Fibrinogen level (mg/dl) | Hazard ratio | 95% CI | P value | |
|---|---|---|---|---|
| Crude | <284 | Ref | <0.0001 | |
| ≥284 | 3.33 | 2.15-5.15 | ||
| Model 1 | <284 | Ref | <0.0001 | |
| ≥284 | 3.35 | 1.95-5.76 | ||
| Model 2 | <284 | Ref | <0.0001 | |
| ≥284 | 3.11 | 1.81-5.36 | ||
| Model 3 | <284 | Ref | <0.0001 | |
| ≥284 | 3.13 | 1.82-5.40 | ||
| Model 4 | <284 | Ref | <0.0001 | |
| ≥284 | 2.83 | 1.63-4.90 | ||
| Model 5 | <284 | Ref | <0.0001 | |
| ≥284 | 2.85 | 1.65-4.92 |
Adjusted covariates: model 1 = fibrinogen, PLT, NT-proBNP, vasopressor use, and ventilator use; model 2 = model 1+HBP, Af, respiratory failure, CKD, and STEMI; model 3 = model 2+SIRS scores (VIF 4.24); model 4 = model 2+APS III scores (VIF 3.94); model 5 = model 2+SAPS II scores (VIF 4.22).